Abstract: There is provided a method and a system for determining recommended multiple daily injections (MDI) therapy values for administering to a given subject. Consumed meals, insulin basal doses administered and insulin bolus doses administered to the given subject are received. An initial meal ratio parameter and an initial basal insulin dose used by the given subject are received. A predicted glucose concentration parameter is determined based on the consumed meals, the insulin basal dose, the insulin bolus doses, and the initial meal ratio parameter. An actual glucose concentration parameter is received. A set of optimal MDI therapy parameters are estimated using the predicted glucose concentration parameter, and the actual glucose concentration parameter.

Abstract: The present invention provides compositions and methods for due date and time to birth prediction for a pregnancy with significantly higher accuracy than current clinical methods. The compositions and methods for due date and time to birth prediction for a pregnancy can also identify those pregnancies that will deliver earlier than the due date derived from LMP and/or US dating.

Abstract: Compositions and methods for predicting due date and time to birth for a pregnancy with significantly higher accuracy than current clinical methods. The compositions and methods for predicting due date and time to birth for a pregnancy can also identify those pregnancies that will deliver earlier than the due date derived from Last Menstrual Period (LMP) and/or obstetric ultrasonography (US) dating.

Abstract: Systems, devices, and methods are provided for operating a watercraft vessel. The system can include a communication unit configured to receive a position signal and a velocity signal of the first vessel. The system can include a first sensing unit configured to determine a relative position signal of one or more nearby vessels including the first vessel, a second sensing unit configured to detect and measure a fluid velocity field of a vortex around the watercraft vessel, and a third sensing unit configured to detect and measure an efficiency gain from a lifting force experienced by watercraft vessel operating in an upwash region of the vortex. And the system can include a control unit configured to maneuver the watercraft vessel from a first position to an optimum position.

Abstract: Artificial intelligence (AI) assisted technology for grocery recommendations and nutrient optimization includes an intuitive application (app) that can use AI to improve grocery recommendations during grocery shopping to optimize nutrition and encourage users to purchase foods that can help the user receive more complete nutrition. Automatically capturing nutritional information while grocery shopping can assist users seeking to improve their health because it operates while users are performing their grocery shopping, when users have the best opportunity to shape the foods that will be available to them to consume. Nutritional optimization while grocery shopping can improve the use of resources including time and money (due to the cost of food) because it can provide suggestions to address nutritional opportunities that represent nutritional surpluses and nutritional opportunities that represent nutritional deficits.

Abstract: Systems, devices, and methods are provided for operating a watercraft vessel. The system can include a communication unit configured to receive a position signal and a velocity signal of the first vessel. The system can include a first sensing unit configured to determine a relative position signal of one or more nearby vessels including the first vessel, a second sensing unit configured to detect and measure a fluid velocity field of a vortex around the watercraft vessel, and a third sensing unit configured to detect and measure an efficiency gain from a lifting force experienced by watercraft vessel operating in an upwash region of the vortex. And the system can include a control unit configured to maneuver the watercraft vessel from a first position to an optimum position.

Abstract: There is provided a method and a system for determining recommended multiple daily injections (MDI) therapy values for administering to a given subject. Consumed meals, insulin basal doses administered and insulin bolus doses administered to the given subject are received. An initial meal ratio parameter and an initial basal insulin dose used by the given subject are received. A predicted glucose concentration parameter is determined based on the consumed meals, the insulin basal dose, the insulin bolus doses, and the initial meal ratio parameter. An actual glucose concentration parameter is received. A set of optimal MDI therapy parameters are estimated using the predicted glucose concentration parameter, and the actual glucose concentration parameter.

Abstract: Systems, devices, and methods are provided for operating a watercraft vessel. The system can include a communication unit configured to receive a position signal and a velocity signal of the first vessel. The system can include a first sensing unit configured to determine a relative position signal of one or more nearby vessels including the first vessel, a second sensing unit configured to detect and measure a fluid velocity field of a vortex around the watercraft vessel, and a third sensing unit configured to detect and measure an efficiency gain from a lifting force experienced by watercraft vessel operating in an upwash region of the vortex. And the system can include a control unit configured to maneuver the watercraft vessel from a first position to an optimum position.

Abstract: The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. The present invention also provides compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC).

Abstract: Systems, devices, and methods are provided for operating a watercraft vessel. The system can include a communication unit configured to receive a position signal and a velocity signal of the first vessel. The system can include a first sensing unit configured to determine a relative position signal of one or more nearby vessels including the first vessel, a second sensing unit configured to detect and measure a fluid velocity field of a vortex around the watercraft vessel, and a third sensing unit configured to detect and measure an efficiency gain from a lifting force experienced by watercraft vessel operating in an upwash region of the vortex. And the system can include a control unit configured to maneuver the watercraft vessel from a first position to an optimum position.

Abstract: Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC).

Abstract: Provided herein are methods for developing selected reaction monitoring mass spectrometry (LC-SRM-MS) assays.

Abstract: The present invention provides compositions and methods for due date and time to birth prediction for a pregnancy with significantly higher accuracy than current clinical methods. The compositions and methods for due date and time to birth prediction for a pregnancy can also identify those pregnancies that will deliver earlier than the due date derived from LMP and/or US dating.

Abstract: Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC).

Abstract: The present application provides stable peptide-based Akt capture agents and the use thereof as detection, diagnosis, and treatment agents. The application further provides novel methods of developing stable peptide-based capture agents, including Akt capture agents, using iterative on-bead in situ click chemistry.

Abstract: The present application provides stable peptide-based Akt capture agents and the use thereof as detection, diagnosis, and treatment agents. The application further provides novel methods of developing stable peptide-based capture agents, including Akt capture agents, using iterative on-bead in situ click chemistry.

Abstract: Provided herein are methods for developing selected reaction monitoring mass spectrometry (LC-SRM-MS) assays.

Abstract: Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC).

Abstract: Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC).

Abstract: The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. The present invention also provides compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC).